Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone loss
Anne-Priscille Trouvin, Vincent GoëbDepartment of Rheumatology, Rouen University Hospital, Rouen, FranceAbstract: Bone remodeling requires a precise balance between resorption and formation. It is a complex process that involves numerous factors: hormones, growth factors, vitamins, and cyto...
Guardado en:
Autores principales: | Anne-Priscille Trouvin, Vincent Goëb |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1d621b844c5b47c2b20e107b72a9fbe1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Treatment of primary osteoporosis in men
por: Giusti A, et al.
Publicado: (2014) -
Effect of Lovastatin on Serum Osteoprotegerin Level in Type 2 Diabetic Nephropathy
por: N Nezami,, et al.
Publicado: (2012) -
Effects of Strontium Ranelate on Alveolar Ridge Morphology Augmentation
por: Xuan,Jing, et al.
Publicado: (2017) -
Incorporation of Bone Morphogenetic Protein-2 and Osteoprotegerin in 3D-Printed Ti6Al4V Scaffolds Enhances Osseointegration Under Osteoporotic Conditions
por: Xianggang Wang, et al.
Publicado: (2021) -
New Generation of Meso and Antiprogestins (SPRMs) into the Osteoporosis Approach
por: Magdalena Woźniczka, et al.
Publicado: (2021)